Recombinant Human CXCR7 Protein，His

CXCR7, also known as C-X-C chemokine receptor type 7, is a G-protein coupled receptor that plays a critical role in various physiological and pathological processes, including immune responses, cancer progression, and cardiovascular diseases. Initially identified as a receptor for the chemokines CXCL11 and CXCL12, it is now recognized for its function in modulating cellular migration and signaling pathways. Research has indicated that CXCR7 may act as a scavenger receptor, regulating the availability of its ligands and contributing to their receptor signaling. The involvement of CXCR7 in tumor microenvironments has led to interest in its potential as a therapeutic target. Overexpression of CXCR7 has been linked to poor prognosis in several cancers, highlighting the necessity for a better understanding of its biochemical properties and interactions. Recombinant protein technology has emerged as a valuable tool to investigate CXCR7's structure and function. By producing and purifying CXCR7 as a recombinant protein, researchers can explore its binding affinities, signaling cascades, and interactions with other molecules. This foundational knowledge could lead to novel strategies for targeting CXCR7 in disease contexts, implicating significant implications for drug development and therapeutic interventions aimed at mitigating cancer and enhancing immune responses. Overall, the study of CXCR7 recombinant proteins is crucial in delineating its biological roles and therapeutic potential, thereby contributing to advancements in biomedical science and novel treatment modalities.